BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18584172)

  • 1. Report on the first international symposium on cancer biology (ISCB), November 14-16, 2007, at the National Institute of Immunology, New Delhi, India.
    Suri A
    Cancer Immunol Immunother; 2009 Feb; 58(2):311-6. PubMed ID: 18584172
    [No Abstract]   [Full Text] [Related]  

  • 2. Second International Symposium on Cancer Biology (ISCB), November 14-16, 2011, at the National Institute of Immunology, New Delhi, India.
    Suri A; Saini S; Gupta N
    Cancer Immunol Immunother; 2012 Oct; 61(10):1877-82. PubMed ID: 22806092
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer immunotherapy: current status and future directions.
    Ito F; Chang AE
    Surg Oncol Clin N Am; 2013 Oct; 22(4):765-83. PubMed ID: 24012398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symposium Report: International Symposium on Ciliate Biology, India Habitat Centre, New Delhi, India, 04-06 April 2018.
    Kamra K; Kaur H; Na S; Abraham JS; Somasundaram S; Makhija S; Toteja R; Warren A; Gupta R
    J Eukaryot Microbiol; 2019 Nov; ():. PubMed ID: 31691429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor immunology at the service of cancer immunotherapy.
    Finn OJ
    Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.
    Gulley JL; Repasky EA; Wood LS; Butterfield LH
    J Immunother Cancer; 2017 Jul; 5(1):55. PubMed ID: 28716068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer vaccines: looking to the future. Interview by Jenaid Rees.
    Apostolopoulos V
    Expert Rev Vaccines; 2013 Oct; 12(10):1125-6. PubMed ID: 24093953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
    Jäger E; Jäger D; Knuth A
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
    [No Abstract]   [Full Text] [Related]  

  • 9. New perspectives in cancer immunotherapy and immunomonitoring.
    Umansky V; Malyguine A; Shurin M
    Future Oncol; 2009 Sep; 5(7):941-4. PubMed ID: 19792962
    [No Abstract]   [Full Text] [Related]  

  • 10. Abstracts of the Albert B. Sabin Vaccine Institute 4th Annual Colloquium on Cancer Vaccines and Immunotherapy. 6-10 March 2002, Walker's Cay, Bahamas.
    Cancer Immunol Immunother; 2003 Mar; 52 Suppl():S1-38. PubMed ID: 12656062
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccines targeting tumor vasculature: a new approach for cancer immunotherapy.
    Croix BS
    Cytotherapy; 2007; 9(1):1-3. PubMed ID: 17354097
    [No Abstract]   [Full Text] [Related]  

  • 12. "Tumor immunology meets oncology" (TIMO) X, May 23-24, 2014, Halle/Saale, Germany.
    Quandt D; Seliger B
    Cancer Immunol Immunother; 2015 Apr; 64(4):519-26. PubMed ID: 25680628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31
    Adusumilli PS; Cha E; Cornfeld M; Davis T; Diab A; Dubensky TW; Evans E; Grogan JL; Irving BA; Leidner RS; Olwill SA; Soon-Shiong P; Triebel F; Tuck D; Bot A; Dansey RD; Drake CG; Freeman GJ; Ibrahim R; Patel S; Chen DS
    J Immunother Cancer; 2017; 5():50. PubMed ID: 28649381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor immunology top 10 list.
    Finn OJ
    Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings of the 7th International Cancer Vaccine Symposium, September 9-11, 2012, Florence, Italy.
    Ann N Y Acad Sci; 2013 May; 1284():1-86. PubMed ID: 23908987
    [No Abstract]   [Full Text] [Related]  

  • 16. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
    Nelson B
    Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
    [No Abstract]   [Full Text] [Related]  

  • 17. Dendritic cell immunotherapy for the treatment of neoplastic disease.
    Decker WK; Xing D; Shpall EJ
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):113-25. PubMed ID: 16443510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should clinical data be included in experimental studies of cancer immunology?
    Gjertsen BT; Bruserud Ø
    Cancer Immunol Immunother; 2004 Aug; 53(8):677-80. PubMed ID: 15069584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic cancer vaccines.
    Ward S; Dalgleish A
    Vaccine; 2007 Sep; 25 Suppl 2():B1-3. PubMed ID: 17681649
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunology of cancer].
    Abelev GI
    Vestn Ross Akad Med Nauk; 1999; (4):21-5. PubMed ID: 10377879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.